🎉 M&A multiples are live!
Check it out!

Public Comps and Valuation Multiples
for Small Molecules

Benchmark revenue and EBITDA valuation multiples for public comps like Idorsia, Ascentage Pharma Group, Betta Pharmaceuticals, Brightgene Bio-medical and InventisBio Co.

Small Molecules

See analyst estimates and all valuation multiples for Small Molecules
Company EV EV/LTM Revenue EV/LTM EBITDA
$3.7B 35.4x -47.8x
$3.5B 7.7x 20.0x
$3.5B 19.5x 59.9x
$2.6B 3.3x 18.6x
$2.3B 87.3x -65.8x
$2.1B 12.0x -7.0x
$1.8B 6.7x 16.8x
$1.8B 0.7x 5.4x
$1.2B 5.6x 27.0x
$1.2B 5.3x 15.3x
$939M n/a n/a
$838M n/a n/a
$800M 3.9x 16.5x
$745M 3.3x 35.8x
$653M 7.4x 21.1x
$496M 43.1x -2.7x
$478M 5.9x n/a
$313M 1.6x 5.9x
$205M 5.4x n/a
$194M 2.7x -2.7x
$171M 6.2x -7.1x
$129M n/a n/a
$129M n/a -5.8x
$126M 1.3x -15.3x
$117M n/a -27.0x
$78.1M n/a -0.6x
$27.0M 0.3x -0.6x
$11.3M 0.3x n/a
-$29.3M -1.0x 0.3x
-$33.6M -10.0x n/a
-$37.7M n/a n/a
-$70.2M n/a 0.6x
-$202M -6.3x 0.9x

Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.

See analyst estimates and M&A multiples for Small Molecules

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.